课题基金 / 基金详情

Effect of Flavanol-Rich Cocoa Extract in Acute Neurodegenerative Conditions

Effect of Flavanol-Rich Cocoa Extract in Acute Neurodegenerative Conditions
富含黄烷醇的可可提取物对急性神经退行性疾病的作用
批准号:
8117138
负责人:
Sylvain DORE
金额:
$21.76万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-01 至 2013-07-31

项目摘要

项目成果

Sylvain DORE的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):据推测,在急性和慢性神经退行性疾病中,神经细胞死亡的决定因素是由自由基损伤介导的。表儿茶素和可可(Theobroma Cacao),据报道具有神经保护作用和潜在的预防药物,但其潜在的细胞机制仍不清楚。我们的初步结果促使我们将注意力集中在(-)-表儿茶素和富含黄烷醇的可可提取物上,并测试了血红素加氧酶(HO)活性可能参与可可提取物神经保护功能的假设。HO分解血红素(一种氧化剂)形成胆绿素/胆红素(抗氧化剂)、一氧化碳(一种血管扩张剂)和铁(通过增加铁蛋白将起到保护作用),已被证明在氧化应激、缺血、炎症和高血压中发挥保护作用。虽然HO2是结构性表达的,但HO1是可以诱导表达的。因此,通过增加HO1水平来提高这种内源性抗氧化系统的活性,可能是在细胞和器官水平上实现神经保护的一种方式。在我们使用原代神经元培养进行的初步实验中测试的化合物中,表儿茶素是最有效的HO1诱导剂之一。我们使用中风模型的结果也表明,口服表儿茶素可显著预防脑缺血再灌注损伤。总而言之,我们的结果表明,用单一化合物表儿茶素预处理足以提供内源性神经保护,这表明在氧化应激期间没有必要进行共治疗。表儿茶素是可可提取物中最丰富的黄烷醇--而且很可能是可可提取物本身。这些初步结果表明,HO1的特异性诱导可能是可可提取物发挥神经保护作用的机制之一,并促使我们提出可可提取物的一些神经保护作用可能是通过刺激内源抗氧化途径来介导的。在目标1中,我们将确定用表儿茶素和/或富含黄烷醇的可可提取物预处理(急性或长期)的野生型(WT)小鼠的神经细胞死亡和行为结果,并在基因敲除小鼠中测试这些影响是否减弱。在目标2中,我们将确定表儿茶素和/或富含黄烷醇的可可提取物诱导HO1表达的变化是否会导致来自WT和基因敲除小鼠的神经细胞培养的细胞存活率发生变化。总之,这些结果将帮助我们确定食用标准化可可提取物是否有益,以及可可提取物为大脑提供对急性衰弱神经退行性疾病的抵抗力的途径。 与公共卫生相关:几个世纪以来,可可一直被报道为加强神经系统的预防药物,但其潜在的细胞机制仍不清楚。我们的初步结果促使我们将注意力集中在表儿茶素和可可提取物上,并测试了导致血红素加氧酶(HO)酶诱导的途径可能参与可可的神经保护功能的假设。HO分解血红素(一种促氧化剂)形成胆绿素/胆红素(抗氧化剂),已被证明在氧化应激、缺血、炎症和高血压方面起到保护作用。利用临床前实验室小鼠模型,我们将确定预防性食用富含黄烷醇的标准化可可提取物是否可以防止全球缺血后神经功能衰退和神经细胞死亡;从而提供新的途径,使可可能够提供对急性神经疾病的大脑抵抗。
英文摘要
DESCRIPTION (provided by applicant): It has been postulated that the determinants of neuronal cell death in acute and chronic neurodegenerative conditions are mediated by free radical damage. Epicatechin and cocoa (Theobroma cacao), has been reported to be neuroprotective and a potential preventive medicine, but the underlying cellular mechanisms are still unclear. Our preliminary results prompted us to focus our attention on (-)-epicatechin and flavanol-rich cocoa extract and test the hypothesis that heme oxygenase (HO) activity could participate in cocoa extract neuroprotective function. HO, which cleaves heme (a prooxidant) to form biliverdin/bilirubin (antioxidants), carbon monoxide (a vasodilator), and iron (which by increasing ferritin would be protective) has been shown to play a protective role in oxidative stress, ischemia, inflammation, and hypertension. Although HO2 is constitutively expressed, HO1 is inducible. Consequently, an increase in the activity of this endogenous antioxidant system via an increase in HO1 levels, could be a way to achieve neuroprotection both at a cellular and organ levels. Of the compounds tested in our preliminary experiments using primary neuronal cultures, epicatechin was one of the most potent HO1 inducers. Our results using stroke models also suggest that epicatechin given orally significantly prevented ischemic-reperfusion brain damage. Together, our results indicate that pretreatment with the single compound epicatechin which is the flavanol most enriched in cocoa extract - and likely to cocoa extract itself - is sufficient to provide endogenous neuroprotection, suggesting that co-treatment during oxidative stress is not necessary. These preliminary results implied that specific induction of HO1 could be a mechanism by which cocoa extract exerts its neuroprotective actions and motivated us to propose that some of the neuroprotective effects attributed to Cocoa extract could be mediated through a pathway leading to stimulation of an endogenous antioxidant pathway. In Aim 1, we will determine neuronal cell death and behavioral outcomes following global ischemia in wildtype (WT) mice pre-treated (acutely or chronically) with epicatechin and/or flavanol-rich cocoa extract and test whether these effects are attenuated in knockout mice. In Aim 2, we will determine whether changes in HO1 expression induced by epicatechin and/or flavanol-rich cocoa extract result in changes in cell survival in neuronal cultures derived from WT and knockout mice. Together, these results will help us determine whether consumption of a standardized cocoa extract could be beneficial and the pathways by which cocoa extract could provide the brain with resistance to acute debilitating neurodegenerative conditions. PUBLIC HEALTH RELEVANCE: For centuries, cocoa (Theobroma cacao) has been reported as preventive medicine to strengthen the nervous system, but the underlying cellular mechanisms are still unclear. Our preliminary results prompted us to focus our attention on epicatechin and cocoa extract and test the hypothesis that the pathway leading to heme oxygenase (HO) enzyme induction could participate in cocoa's neuroprotective function. HO, which cleaves heme (a pro-oxidant) to form biliverdin/bilirubin (anti-oxidants) has been shown to play a protective role in oxidative stress, ischemia, inflammation, and hypertension. Using pre-clinical laboratory mouse models, we will determine whether prophylactic consumption of a standardized flavanol-rich cocoa extract can prevent neurological decline and neuronal cell death following global ischemia; thus providing new pathways by which cocoa could provide brain resistance against acute neurological disorders.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Efficacy of prophylactic flavan-3-ol in permanent focal ischemia in 12-mo-old mice.
预防性黄烷-3-醇对 12 个月大小鼠永久性局灶性缺血的疗效。
DOI: 10.1152/ajpheart.00239.2014
发表时间: 2015
期刊: American journal of physiology. Heart and circulatory physiology
影响因子: --
作者: [Leonardo,ChristopherC, Mendes,Monique, Ahmad,AbdullahS, Doré,Sylvain]
通讯作者: Doré,Sylvain
Testing brain penetrant iron chelators and investigating putative clearance pathway in ICH
  • 批准号:
    10201369
  • 项目类别:
  • 资助金额:
    $38.13万
  • 财政年份:
    2020
  • 负责人:
    Sylvain DORE
  • 依托单位:
Potential stroke therapeutic efficacy of FumET-CORM through the Nrf2 pathway
  • 批准号:
    9751526
  • 项目类别:
  • 资助金额:
    $41.94万
  • 财政年份:
    2019
  • 负责人:
    Sylvain DORE
  • 依托单位:
Regulation and Implication of Hemoglobin Clearance in Subarachnoid Hemorrhagic Patients
  • 批准号:
    9332485
  • 项目类别:
  • 资助金额:
    $19.39万
  • 财政年份:
    2016
  • 负责人:
    Sylvain DORE
  • 依托单位:
Regulation and Implication of Hemoglobin Clearance in Subarachnoid Hemorrhagic Patients
  • 批准号:
    9182501
  • 项目类别:
  • 资助金额:
    $23.21万
  • 财政年份:
    2016
  • 负责人:
    Sylvain DORE
  • 依托单位:
海外基金